Mnemo Therapeutics

Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies to create viable treatments for solid tumors and blood cancers. Its EnfiniT platform is a groundbreaking drug discovery engine that leverages a novel antigen with enhanced tumor specificity and a suite of technologies to significantly improve T-cell memory, persistence, and sensitivity. The result is a greatly enhanced immune response to overcome disease. Mnemo is comprised of a transatlantic team of scientists and biotech leaders with the mission to create the most potent immunotherapies and provide accessible treatments for all patients in need.